Attention-deficit/hyperactivity disorder -Epidemiology Forecast to 2027

Attention-deficit/hyperactivity disorder -Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Attention-deficit/hyperactivity disorder (ADHD) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Attention-deficit/hyperactivity disorder (ADHD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Attention-deficit/hyperactivity disorder (ADHD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Attention-deficit/hyperactivity disorder (ADHD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Attention-deficit/hyperactivity disorder (ADHD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Attention-deficit/hyperactivity disorder (ADHD) scenario.

Attention-deficit/hyperactivity disorder (ADHD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Attention-deficit/hyperactivity disorder (ADHD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Attention-deficit/hyperactivity disorder (ADHD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Attention-deficit/hyperactivity disorder (ADHD) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Attention-deficit/hyperactivity disorder (ADHD)

Key assessments
• Patient Segmentation in Attention-deficit/hyperactivity disorder (ADHD)
• Attention-deficit/hyperactivity disorder (ADHD) Risk & Burden
• Factors driving growth in a specific Attention-deficit/hyperactivity disorder (ADHD) patient population
1. Report Introduction
2. Attention-deficit/hyperactivity disorder (ADHD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Attention-deficit/hyperactivity disorder (ADHD) in 2017
2.2. Patient Share Distribution of Attention-deficit/hyperactivity disorder (ADHD) in 2027
3. Disease Background and Overview: Attention-deficit/hyperactivity disorder (ADHD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Attention-deficit/hyperactivity disorder (ADHD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Attention-deficit/hyperactivity disorder (ADHD) in 7MM – By Countries
5. Epidemiology of Attention-deficit/hyperactivity disorder (ADHD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.1.3. Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) *
5.1.4. Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.1.5. Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.4.3. Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.4.4. Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.4.5. Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.5.3. Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.5.4. Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.5.5. Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.6.3. Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.6.4. Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.6.5. Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.7.3. Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.7.4. Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.7.5. Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.8.3. Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.8.4. Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.8.5. Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD)
5.9.3. Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.9.4. Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD)*
5.9.5. Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD)
6. Unmet Needs of the Attention-deficit/hyperactivity disorder (ADHD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD) in United States (2016-2027)*
Table 6: Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in France (2016-2027)
Table 12: Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) in France (2016-2027) *
Table 13: Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD) in France (2016-2027) *
Table 14: Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD) in UK (2016-2027) *
Table 26: Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Attention-deficit/hyperactivity disorder (ADHD) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Attention-deficit/hyperactivity disorder (ADHD) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us